|

TG THERAPEUTICS INC (TGTX)

US88322Q1085 - Common Stock

15.72  -0.31 (-1.93%)

After market: 15.68 -0.04 (-0.25%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
150K6.69M
4,360.00%		2.79M
-58.30%		234.02M
8,287.81%
EBITDA
YoY % growth
-273.43M
-61.83%		-344.49M
-25.99%		-192.54M
44.11%		-64.322M
66.59%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
-273.59M
-61.83%		-344.77M
-26.02%		-192.84M
44.07%		-98.879M
48.73%
Operating Margin
-182,393.33%-5,153.51%-6,911.83%-42.25%
EPS
YoY % growth
-2.27
-14.65%		-2.63
-15.86%		-1.46
44.49%		0.04
102.45%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		-0.12
69.74%
Revenue
Q2Q % growth		39.458M
39,358.00%
EBITDA
Q2Q % growth		-21.42MN/AN/AN/AN/A
EBIT
Q2Q % growth		-16.836M
67.69%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2023
Q2Q % growth		 0.73
380.77%		0.120.61518.52%
Q2 2023
Q2Q % growth		 -0.34
-13.33%		-0.25-0.09-34.00%
Q1 2023
Q2Q % growth		 -0.28
45.10%		-0.370.0925.23%
Q4 2022
Q2Q % growth		 -0.39
44.29%		-0.27-0.12-47.06%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2023
Q2Q % growth		 165.8M
165,700.00%		47.492M118.308M249.11%
Q2 2023
Q2Q % growth		 16.1M
2,583.33%		17.802M-1.702M-9.56%
Q1 2023
Q2Q % growth		 7.8M
290.00%		3.447M4.353M126.28%
Q4 2022
Q2Q % growth		 100K
-95.65%		1.864M-1.764M-94.64%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 38.64% 105.73% 104.79%
Revenue0% -0.91% 61.64% 58.21%